OPT failed Ph3 clinical trial (I'm not even sure how the the results can be so different from Ph2????), the clinical trial updates for VAXINIA and Azer-Cel were excellent which was why the pps reacted positively on the announcement. I would buy more if the pps goes down to 2c as this is CVI's target otherwise wait until IMU released further positive clinical trial update and load up even more at 5c.
IMU Price at posting:
2.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)